Access to Medicine Index 2014

26

0 1 2 3 4 5

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

1

6

2

7

5

8

4

3

n/a

9

15

10

12

17

16

11

14

20

19

18

3.29

3.01

2.84

2.84

2.81

2.77

2.64

2.57

2.56

2.51

2.47

2.30

2.23

2.08

1.94

1.93

1.73

1.56

1.50

1.45

GlaxoSmithKline plc

Novo Nordisk A/S

Johnson & Johnson

Novartis AG

Gilead Sciences Inc.

Merck KGaA

Merck & Co. Inc.

Sano�

AbbVie Inc.

Bayer AG

Eisai Co. Ltd.

Roche Holding AG

Bristol-Myers Squibb Co.

Boehringer Ingelheim GmbH

AstraZeneca plc

P�zer Inc.

Eli Lilly & Co.

Astellas Pharma Inc.

Daiichi Sankyo Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

Overall Company Ranking

General Access to Medicine Management

Public Policy & Market In�uence

Research & Development

Pricing, Manufacturing & Distribution

Patents & Licensing

Capability Advancement in Product Development & Distribution

Product Donations & Philanthropic Activities

The Access to Medicine Index 2014 – Overall Ranking

Position

Access to Medicine

Index 2012

Position

Access to Medicine

Index 2014

Figure 10

A score of zero means lowest and five signifies highest indicator score among the company set.